연구동향 분석

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers

Yingjia Wu Jinbin Chen Lei Zhao Qiaoqiao Li Jinhan Zhu Hong Yang Suping Guo Mian Xi 년

논문상세정보
인용/피인용

' Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers' 의 참고문헌

  • Treatmentrelated lymphopenia predicts pathologic complete response and recurrence in esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy
    Li Q [2019]
  • Towards an organ-sparing approach for locally advanced esophageal cancer
  • The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer
    Tustumi F [2020]
  • The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy
    Deng W [2019]
  • Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer
    허재성 [2016]
  • Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma : an updated meta-analysis
    Sjoquist KM [2011]
  • Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer : final analysis of randomized controlled phase III trial FFCD 9901
    Mariette C [2014]
  • Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer : a propensity matched analysis of the relative risk of proton versus photon-based radiation therapy
    Shiraishi Y [2018]
  • Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer
    Scheer RV [2011]
  • Prognostic value of preoperative systemic immunoinflammatory measures in patients with esophageal cancer
    Ishibashi Y [2018]
  • Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer
    Suzuki R [2018]
  • Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma
    Hirahara N [2017]
  • Preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal cancer using(18)F-FDG PET/CT and DW-MRI : a prospective multicenter study
  • Preoperative chemoradiotherapy for esophageal or junctional cancer
    van Hagen P [2012]
  • Prediction of response to neoadjuvant chemotherapy and radiation therapy with baseline and restaging(18)F-FDG PET imaging biomarkers in patients with esophageal cancer
    Beukinga RJ [2018]
  • Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
    Conroy T [1996]
  • Nomograms predict overall survival for patients with smallcell lung cancer incorporating pretreatment peripheral blood markers
    Xie D [2015]
  • Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer
    Toxopeus EL [2015]
  • Neutrophil-to-lymphocyte and plateletto-lymphocyte ratios can predict treatment response to neoadjuvant therapy in esophageal cancer
    McLaren PJ [2017]
  • Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma : a matched case-control study
    Liu SL [2015]
  • Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer(CROSS) : long-term results of a randomised controlled trial
    Shapiro J [2015]
  • Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus(NEOCRTEC5010) : a phase III multicenter, randomized, open-label clinical trial
    Yang H [2018]
  • Multi-institutional analysis of recurrence and survival after neoadjuvant chemoradiotherapy of esophageal cancer : impact of histology on recurrence patterns and outcomes
    Xi M [2019]
  • Lymphopenia in esophageal squamous cell carcinoma : relationship to malnutrition, various disease parameters, and response to concurrent chemoradiotherapy
    Zhou XL [2019]
  • Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy
    Davuluri R [2017]
  • Indoleamine 2, 3-dioxygenase 1 and programmed cell death-ligand 1co-expression predicts poor pathologic response and recurrence in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
    Zhou S [2019]
  • Immunity, inflammation, and cancer
  • High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer
    Fang P [2018]
  • Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
    Chao YK [2017]
  • Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer(preSANO) : a prospective multicentre, diagnostic cohort study
    Noordman BJ [2018]
  • Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer
    Ajani JA [2012]
  • Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer
    Azad TD [2020]
  • Cancer-related inflammation
    Mantovani A [2008]